Pharmacare legislation includes universal access to contraception and diabetes medications.
Canadians should have access to quality medicines, regardless of where they live or their ability to pay. People should not have to choose between paying for their medications and putting food on the table. Unfortunately, many Canadians are still forced to make this impossible decision.
That's why, today, the Honourable Marci Ien, Minister for Women and Gender Equality and Youth, joined the Honourable Filomena Tassi, Minister responsible for the Federal Economic Development Agency for Southern Ontario, the Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, and Lisa Hepfner, Parliamentary Secretary to the Minister for Women and Gender Equality and Youth, to reiterate the Government of Canada's commitment to help make essential and preventive medications more accessible and affordable, on behalf of the Honourable Mark Holland, Minister of Health.
In February 2024, the Government of Canada introduced legislation that proposes foundational principles for the first phase of national universal pharmacare in Canada and the intent to work with provinces and territories to provide universal, single-payer coverage for a number of contraceptives and diabetes medications. The Pharmacare Act is a concrete step towards the vision of a national pharmacare program that is accessible, inclusive, and fiscally sustainable-today and for the next generation.
Coverage for contraceptives will mean that nine million Canadians of reproductive age will have better access to contraception and reproductive autonomy, reducing the risk of unintended pregnancies and improving their ability to plan for the future. Cost has consistently been identified as the single most important barrier to accessing these medications and the cost is unevenly borne by women and gender-diverse Canadians. Canadians of reproductive age will now have affordable access to a comprehensive suite of contraceptive drugs and devices.
Diabetes is a complex disease that has no cure, but can be treated with safe and effective medications. However, one in four Canadians with diabetes has reported not following their treatment plan due to cost. Improving access to diabetes medications will help improve the health of 3.7 million Canadians living with diabetes, and reduce the risk of serious life-changing health complications, such as blindness or amputations.
The Government of Canada will consult widely about the way forward and will work with provinces, territories, Indigenous Peoples, and other partners and stakeholders to improve the accessibility, affordability, and appropriate use of pharmaceutical products, by reducing financial barriers and contributing to physical and mental health and well-being.
Financial barriers should not be the reason people cannot access prescription drugs and related products. We are determined to work towards a plan where Canadians can obtain their medication as prescribed, regardless of where they live or their ability to pay. This is an important step forward to improving health equity, affordability, and health outcomes, as well as having the potential of long-term savings to the health care system.
